Buclizine dihydrochloride is an antihistamine medication belonging to the piperazine derivative class, utilized for its antiemetic and anticholinergic properties to manage conditions such as motion sickness… Read more
Buclizine dihydrochloride is an antihistamine medication belonging to the piperazine derivative class, utilized for its antiemetic and anticholinergic properties to manage conditions such as motion sickness and vertigo. While there is historical mention of its use as an appetite stimulant, this application lacks clinical validation. Laboratories working with this compound require high-quality reference standards, including the active pharmaceutical ingredient, to facilitate rigorous quality control and analytical method development. The study of this drug requires precise identification of related substances, making pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled compounds essential for accurate impurity profiling and quantitative analysis. By utilizing these specialized materials, researchers can ensure compliance with regulatory standards and maintain the integrity of pharmaceutical testing protocols for this piperazine derivative.